Pendulum GLP-1 Probiotic review: packaging, storage and recurring terms

The official product gallery shows older and newer bottle designs with a statement that the formula is unchanged and either package may arrive during the transition. That is a seller description, not authentication of a bottle this publication received. The pictured bottle contains thirty capsules, and the facts image states thirty one-capsule servings. The listing-discrepancy guide explains why a matching brand name is insufficient to settle a version question. Keep a selected order and actual package information distinct from general gallery artwork. The publication has not inspected a delivered lot, its best-by marking, protective materials or the conditions in which a retailer held it.

The pictured declaration lists a combined probiotic blend of 500 million AFU: Clostridium butyricum WB-STR-0006, Akkermansia muciniphila WB-STR-0001 and Bifidobacterium infantis without a displayed code. It also lists chicory inulin 211 mg, with microcrystalline cellulose, hypromellose and silica as other ingredients. These details do not allocate the combined amount among organisms or establish a CFU equivalent. NIH’s reference supports preserving exact identity and evidence context. CoreAge’s separate record uses a blend mass and lacks the same counting declaration. Comparing visible numbers cannot create a potency ranking or establish that the preparations share an effect.

The inspected panel says to refrigerate for optimal quality. That wording belongs to this preparation; it does not supply an independently verified temperature history or a universal allowance for time outside refrigeration. We did not inspect a shipping validation report, log or post-delivery count assay. The handling guide distinguishes a manufacturer instruction from what actually happened to a parcel. An arrival observation may be useful to the seller, but an online reviewer cannot translate it into remaining viable organisms. Neither an intact bottle nor a change of packaging supplies that measurement, and another brand’s no-refrigeration statement cannot be used to settle Pendulum’s conditions.

Pendulum attributes its reported cravings figures to a six-week consumer survey involving 274 people: ninety-one percent reported reduced overall cravings and eighty-eight percent reported fewer sugar cravings. These are seller-reported survey outcomes, not proof of a measured GLP-1 increase or relief of prescription adverse effects. The separate 2020 trial studied WBF-010 and WBF-011 in adults with type 2 diabetes; WBF-011 contained five organisms plus inulin. It is not the current three-organism retail preparation. Those research distinctions remain important even in a purchase-focused review. A handling claim, guarantee or survey percentage cannot bridge the difference between a retail formula and a tested intervention.

The official public variant response lists a one-month option at $64 with a thirty-day recurring interval and a three-month option at $173 with a ninety-day interval. A separate one-time purchase is $89. These are full named choices, not interchangeable monthly prices. The three-month charge is not replaced here with a calculated equivalent, and a seller’s supply-period label is not a clinical use recommendation. The purchase checklist keeps the unit, interval and charge together. Public variant availability is not a stock guarantee, and this review did not establish a selected all-in checkout amount, any customer-specific promotion or an actual renewal.

Pendulum’s terms say membership cancellation requests must arrive by the Sunday before the next charge date. They also distinguish later cancellation from refunding an order that has shipped. The first-purchase guarantee for GLP-1 Probiotic uses a thirty-day period beginning at receipt, includes a directed-use condition and permits redemption up to fourteen days after that period ends. These are commercial conditions, not instructions from this publication to start or continue a supplement. Shipping and handling are excluded, and the terms discuss coverage for a first item containing a multi-month quantity. Read the applicable clauses together rather than reduce the arrangement to an unconditional money-back promise.

The same terms state that physical returns are not accepted, while describing circumstances for refund or replacement requests. A refund process therefore should not be assumed to involve returning a bottle or to prove the product caused a problem. Questions about a package, shipment or charge belong with the seller’s documented process. Questions about a health setting belong with an appropriate clinician or pharmacist. The serious-illness guide explains the boundary using federal evidence, and the fixed reader keeps the question types separate. No seller assurance in these records establishes personal eligibility, medicine compatibility or a reason to postpone needed clinical attention.